1135-5727 1135-5727 S1135-57272017000100213 España España España España España 00 00 2017 00 00 2017 91

1 World Health Organization Scientific Group 2008 2 2013 8 3 2000 11 228-32 4 2006 17 464-70 5 2006 368 973-4 6 2011 22 5 5 1537-46 7 Office of the Surgeon General (US) 2004 8 2014 38 8 8 1731-8 9 2014 25 2359-81 10 2014 10 3 3 229-32 11 2015 17 12 2013 24 12 12 2907-18 13 2003 32 180-4 14 2007 207 464-8 15 2005 366 1885-93 16 2000 15 721-39 17 NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy 2001 285 785-95 18 2007 129 418-23 19 2004 35 375-82 20 2014 25 2555-63 21 2007 207 464-8 22 The European Prospective Osteoporosis Study (EPOS) Group 2002 17 716-24 23 1999 9 206-13 24 1999 318 25 2001 116 86-8 26 1997 7 59-64 27 2011 28 2015 7 2 2 54-62 29 2010 42 559-63 30 2016 5 5 31 National Clinical Guideline Centre (UK) 2012 32 2016 12 1 1 33 2003 163 2052-7 34 2011 136 290-2 35 2009 122 36 2011 8 57-62 37 2004 86 958-61 38 2005 16 Suppl 2 Suppl 2 44-53 39 2004 15 405-10 40 2006 88 18-24 41 2007 18 1023-31 42 2008 23 1435-41 43 2005 17 96-9 44 2014 10 5 5 299-303 45 2013 24 393-406 46 2009 301 513-21 47 2009 20 1633-50 48 1999 10 73-8 49 2008 66 111-7 50 2004 52 685-90 51 2010 152 380-90 52 2008 90 2142-8 53 2003 163 2052-7 54 2011 364 1634-42 55 2004 15 120-4